MedCon 2013

At the beginning of this month, MedCon 2013 was hosted in Cincinnati, OH by Xavier University. The three day conference was held Wednesday May 1st, 2013 through Friday May 3rd, 2013.

A wide array of topics was featured in this year’s conference and ranged from new EU regulations, Food and Drug Administration Safety and Innovation Act (FDASIA) to new 510(k) and PMA guidances and Unique Device Identification (UDI).

For me, the two of the most interesting and educational presentations were Paul Brooks' "What's New in the EU?" and "Success in Central and South America" presented by Ann Marie Boullie. “What’s New in the EU?” mainly discussed the transition of the three directives being replaced by two regulations, requirement for parts & components, and registration. "Success in Central and South America" touched on a little bit of everything, ranging from Brazil’s release of new GMPs, Mexico’s de-listing of around 1700 medical devices, and most importantly issues of control & understanding in the Latin American market.

Not only did we learn, we also re-connected and made new connections. RQS re-connected with many people and brought back a wealth of knowledge. In addition to seeing familiar faces, we also met many amazing people in the industry from companies with diverse backgrounds, such as Novatek, Austen BioInnovation, Davis Medical, Cleveland HeartLab, P&G, and Sterigenics. Being able to make these connections and having the opportunity to share ideas, common issues/trends, and information that we learned during the conference with our Medical Device/BioTech community is vital to our industry.

Do you have questions about something that was covered during MedCon? Would you like to begin an open, productive conversation about a topic that was discussed during MedCon? Please, feel free to begin this dialogue with us and leave your comments!

-RSpelich ^_^